Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by cytochromeon Jun 02, 2016 9:45am

164 Views

Post# 24926364

RE:Love the facts...

Hey goofball..here's a fact for you:

However, the average rate of successful translation from animal models to clinical cancer trials is less than 8%.

Reference:
Food and Drug Administration: U. S. Department of Health and Human Services. 2004. Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products.)

The only fact you should be stating is that you are an ignorant uneducated investor. TLT PDC is a huge long shot. Great if it gets past all the hurdles but certainly not a high percentage risk.

Bullboard Posts

AI companies to invest in